Meniscal Transplantation

Reading File
Finding Sources
Finding Sources
Searching PubMed

"meniscal transplantation" OR "meniscus transplantation"

Reading File
Reading File
Here is a comprehensive overview of Meniscal Transplantation based on Miller's Review of Orthopaedics (9th Edition):

Meniscal Allograft Transplantation (MAT)

Overview

Meniscal transplantation is controversial. All nonoperative management modalities should be exhausted before it is considered. The primary goal is pain relief — chondroprotection has not yet been definitively demonstrated clinically. Most available studies have only short-term to 5-year follow-up data.

Indications

CriterionDetail
Prior meniscectomyTotal or near-total meniscectomy, especially the lateral meniscus
PainIn the involved compartment
BMI< 30
AgeYounger than 50 years
Chondral statusAddressable full-thickness chondral lesions (not diffuse)
AlignmentNormal mechanical axis
Ligamentous stabilityKnee must be ligamentously stable
Any ligamentous deficiency or limb malalignment must be corrected prior to or concurrently with transplantation to improve success rates.

Contraindications

  • Diffuse Grade III/IV chondral changes
  • Kissing lesions (opposing chondral defects on femur and tibia)
  • Advanced age
  • Inflammatory arthritis
  • Synovial disease
  • Increased BMI
  • Uncorrected mechanical axis deviation toward the affected compartment
  • Significant osteoarthritis

Graft Sizing

Accurate sizing is critical — the graft must be within 5% of the native meniscus size:
  • Sizing is typically performed using radiographs, but MRI is also acceptable
  • Undersized graft → poor joint congruity + increased load transmission
  • Oversized graft → meniscal extrusion + impaired compressive load transmission

Surgical Techniques

Two main implantation approaches:
  1. Individual bone plugs — for the anterior and posterior horns
  2. Bone bridge technique — particularly used for lateral meniscal transplantation

Outcomes & Biology

  • Pain relief is the most consistent and predictable benefit
  • Chondroprotective effect has not been clinically demonstrated
  • Allograft tissue frequently remains hypocellular or acellular, particularly at the core (incomplete cellular repopulation/revascularization)
  • The most common complication is meniscal tear of the allograft

Collagen Meniscal Implant (CMI)

A biological scaffold alternative for irreparable medial meniscal tears:
  • Promotes new meniscus-like matrix formation
  • Shows promising early results compared to partial meniscectomy
  • Long-term data, especially from independent sources, is lacking

Key High-Yield Points

  • The lateral meniscus is the more common indication (lateral meniscectomy causes greater biomechanical disruption)
  • Partial meniscectomy increases peak stresses in the affected compartment — a key driver of the need for transplantation
  • Concomitant procedures (ACL reconstruction, osteotomy) must address instability and malalignment

Recent Evidence

Two recent systematic reviews (2024–2026) highlight important clinical insights:
  • Wang et al. (2024) (Arthroscopy) — Concomitant treatment of high-grade cartilage lesions mitigates the risk of meniscal allograft transplant failure. [PMID: 38008388]
  • Lin et al. (2026) (Am J Sports Med) — Characterizes the rate of conversion to total knee arthroplasty (TKA) after meniscal allograft transplantation. [PMID: 41476405]
These reinforce the textbook teaching: careful patient selection and addressing concomitant pathology are critical to outcomes.

— Miller's Review of Orthopaedics, 9th Edition, p. 349–350
This is a shared conversation. Sign in to Orris to start your own chat.